Skip to main content
Category

Molecular Endocrinology and Pharmacology

Chronic Kidney DiseaseKidney DiseaseLabMedia ReleasesMolecular Endocrinology and PharmacologyNews & EventsResearchResearch Area

Phase 3 drug trial for rare chronic kidney disease achieves key milestone

By | Chronic Kidney Disease, Kidney Disease, Lab, Media Releases, Molecular Endocrinology and Pharmacology, News & Events, Research, Research Area

Biopharmaceutical company, Dimerix Limited (ASX: DXB, “Dimerix”), which is developing new treatments for types of inflammatory kidney and respiratory diseases, has announced successful interim results of a Phase 3 trial…

Molecular Endocrinology and PharmacologyMolecular MedicineNews & Events

Double hit of new appointments for Head of Molecular Endocrinology and Pharmacology

By | Molecular Endocrinology and Pharmacology, Molecular Medicine, News & Events

Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed President of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) earlier this month. Coincidentally, on…

Epigenetics and Genomics LaboratoryMedia ReleasesMolecular Endocrinology and PharmacologyNews & Events

Dual win sees two Harry Perkins researchers awarded in 2020 Business Events Perth Aspire Awards

By | Epigenetics and Genomics Laboratory, Media Releases, Molecular Endocrinology and Pharmacology, News & Events

Business Events Perth, in partnership with the Harry Perkins Institute of Medical Research, is pleased to announce that the inaugural Harry Perkins Aspire Award has been presented to two applicants:…

CancerChronic Kidney DiseaseDisease AreaLabMolecular Endocrinology and PharmacologyMolecular MedicineNews & EventsResearchResearch Area

New way to examine how medicines act on cells

By | Cancer, Chronic Kidney Disease, Disease Area, Lab, Molecular Endocrinology and Pharmacology, Molecular Medicine, News & Events, Research, Research Area

Using a genome editing technique called CRISPR/Cas9, the researchers attached a super-bright glowing molecule, derived from deep sea shrimp, to specific molecules important for signalling in cancer cells, ‘receptors’. Receptors…